News

Patented Medicine Prices Review Board will hear closing arguments in the matter of the price of Soliris

April 12, 2017

Proceedings to resume April 18, 2017 in Ottawa.


High-price specialty drugs dominate international new drug launches and sales in 2015

April 11, 2017

The Patented Medicine Prices Review Board, through the National Prescription Drug Utilization Information System research initiative, today published the first edition of Meds Entry Watch, a new annual publication that provides information on recently launched drugs in Canada and select international markets.


Patented Medicine Prices Review Board will hear evidence in the matter of the price of orphan drug Soliris

February 15, 2017

Proceedings to resume February 20, 2017 in Ottawa.


Patented Medicine Prices Review Board seeks applicants for Chairperson and Board member positions

February 13, 2017

Governor in Council selection processes underway.


Patented Medicine Prices Review Board will hear evidence in the matter of the price of orphan drug Soliris

January 11, 2017

Proceedings to begin in January 2017 in Ottawa.


PAGE 1 - 2 - 3 - 4 - 5  NEXT 25  LAST 5 
Date modified: